ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /反応

1,2-Dichloroethane → N-[4-[(4-{[6-chloro-4-(5-methoxy-1H-pyrrolo[2,3-b]pyridin-3-yl)pyridin-2-yl]amino}cyclohexyl)methyl]cyclohexyl]cyclopropanecarboxamide

HRID 2089046
印刷

反応式

HRID 2089046 の反応式
[NH2:1][CH:2]1[CH2:7][CH2:6][CH:5]([CH2:8][CH:9]2[CH2:14][CH2:13][CH:12]([NH:15][C:16]3[CH:21]=[C:20]([C:22]4[C:30]5[C:25](=[N:26][CH:27]=[C:28]([O:31][CH3:32])[CH:29]=5)[NH:24][CH:23]=4)[CH:19]=[C:18]([Cl:33])[N:17]=3)[CH2:11][CH2:10]2)[CH2:4][CH2:3]1.[CH:34]1([C:37](O)=[O:38])[CH2:36][CH2:35]1.C1C=CC2N(O)N=NC=2C=1.C(Cl)CCl.C(N(CC)CC)C>CN(C=O)C.O>[Cl:33][C:18]1[N:17]=[C:16]([NH:15][CH:12]2[CH2:11][CH2:10][CH:9]([CH2:8][CH:5]3[CH2:6][CH2:7][CH:2]([NH:1][C:37]([CH:34]4[CH2:36][CH2:35]4)=[O:38])[CH2:3][CH2:4]3)[CH2:14][CH2:13]2)[CH:21]=[C:20]([C:22]2[C:30]3[C:25](=[N:26][CH:27]=[C:28]([O:31][CH3:32])[CH:29]=3)[NH:24][CH:23]=2)[CH:19]=1
参加物実験手順後処理出典と根拠反応ノート

参加物

8

反応物 5

HCID 111,2-Dichloroethane2 回HCID 8471Triethylamine2 回HCID 15655Cyclopropanecarboxylic acidHCID 757711-Hydroxybenzotriazole2 回HCID 87191065N-{4-[(4-aminocyclohexyl)methyl]cyclohexyl}-6-chloro-4-(5-methoxy-1H-pyrrolo[2,3-b]pyridin-3-yl)pyridin-2-amine

生成物 1

HCID 87191602
N-[4-[(4-{[6-chloro-4-(5-methoxy-1H-pyrrolo[2,3-b]pyridin-3-yl)pyridin-2-yl]amino}cyclohexyl)methyl]cyclohexyl]cyclopropanecarboxamide
収率 37.1%

試薬・触媒・溶媒 2

HCID 962Water溶媒HCID 6228Dimethylformamide溶媒

実験手順

A mixture of Example 237 (68.5 mg, 0.146 mmol), cyclopropanecarboxylic acid (0.013 mL, 0.161 mmol), HOBT (26.9 mg, 0.176 mmol), EDC (33.7 mg, 0.176 mmol), and triethylamine (0.027 mL, 0.190 mmol) in DMF (2.5 mL) was stirred at room temperature overnight. More EDC (0.6 eq), HOBT (0.6 eq), acid (0.6 eq) and triethylamine (0.7 eq) were added. After 6 hours, water was added to reaction mixture. The precipitate was filtered and purified by reverse-phase HPLC as described in Example 56 to give the title compound (29.0 mg) as trifluoroacetic acid salts. 1H NMR (400 MHz, CD3OD) ppm 0.67-0.76 (m, 2H), 0.77-0.87 (m, 2H), 0.93-1.45 (m, 12H), 1.47-1.96 (m, 10H), 3.57 (m, 1H), 3.71 (m, 1H), 87 (m, 0.6H), 3.96 (s, 3H), 4.02 (m, 0.4H), 6.88-7.07 (m, 2H), 7.94 (m, 1H), 8.04 (s, 1H), 8.11 (s, 1H). MS (DCI+) m/z 536.4 (M+H)+.

後処理

  1. filtrationThe precipitate was filtered
  2. custompurified by reverse-phase HPLC

出典と根拠

ORDレコード
ord-df35283ac11f4455b129bd59e1578034
出典データセット
uspto-grants-2013_05
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US08435980B2

反応ノート

このページの内容参加物実験手順後処理出典と根拠反応ノート